ProfileGDS5822 / ILMN_2600763
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 60% 60% 63% 54% 57% 26% 64% 49% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 128.860
GSM1276600PDAC Late Ablation Control 231.460
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 130.563
GSM1276603PDAC Late Ablation 225.554
GSM1276604PDAC Late Ablation 329.757
GSM1303940PDAC Late Ablation_anti-CTLA4 114.526
GSM1303941PDAC Late Ablation_anti-CTLA4 243.664
GSM1303942PDAC Late Ablation_anti-CTLA4 325.249